5 Abilify Diabetes Lawsuits Dismissed By New York Court For Forum Non Conveniens

(November 11, 2015, 9:18 AM EST) -- NEW YORK — A New York state court justice on Oct. 23 dismissed five Abilify diabetes cases on the grounds of forum non conveniens provided defendants Bristol-Myers Squibb Co. (BMS) and...
To view the full article, register now.